Australian Clinical Labs
ACL.AX
#6988
Rank
NZ$0.76 B
Marketcap
$3.82
Share price
-1.43%
Change (1 day)
25.83%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: $0.21

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is $0.21. In 2023 the company made an earnings per share (EPS) of $0.21 a decrease over its 2022 EPS that were of $1.08.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023$0.21-80.55%
2022$1.08104.3%
2021$0.53